Many enveloped viruses induce multinucleated cells (syncytia), reflective of membrane fusion events caused by the same machinery that underlies viral entry. These syncytia are thought to facilitate replication and evasion of the host immune response. Here, we report that co-culture of human cells expressing the receptor ACE2 with cells expressing SARS-CoV-2 spike, results in synapse-like intercellular contacts that initiate cell-cell fusion, producing syncytia resembling those we identify in lungs of COVID-19 patients. To assess the mechanism of spike/ACE2-driven membrane fusion, we developed a microscopy-based, cell-cell fusion assay to screen ~6000 drugs and >30 spike variants. Together with quantitative cell biology approaches, the screen reveals an essential role for biophysical aspects of the membrane, particularly cholesterol-rich regions, in spike-mediated fusion, which extends to replication-competent SARS-CoV-2 isolates. Our findings potentially provide a molecular basis for positive outcomes reported in COVID-19 patients taking statins, and suggest new strategies for therapeutics targeting the membrane of SARS-CoV-2 and other fusogenic viruses.
pan class="Gene">Many enveloped viruses induce n>an class="Gene">multinucleated cells (syncytia), reflective of membranefusion events caused by the same machinery that underlies viral entry. These syncytia are thought to facilitate replication and evasion of the host immune response. Here, we report that co-culture of human cells expressing the receptor ACE2 with cells expressing SARS-CoV-2spike, results in synapse-like intercellular contacts that initiate cell-cell fusion, producing syncytia resembling those we identify in lungs of COVID-19patients. To assess the mechanism of spike/ACE2-driven membranefusion, we developed a microscopy-based, cell-cell fusion assay to screen ~6000 drugs and >30 spike variants. Together with quantitative cell biology approaches, the screen reveals an essential role for biophysical aspects of the membrane, particularly cholesterol-rich regions, in spike-mediated fusion, which extends to replication-competent SARS-CoV-2 isolates. Our findings potentially provide a molecular basis for positive outcomes reported in COVID-19patients taking statins, and suggest new strategies for therapeutics targeting the membrane of SARS-CoV-2 and other fusogenic viruses.
Authors: Daniella Cesar-Silva; Filipe S Pereira-Dutra; Ana Lucia Moraes Giannini; Cecília Jacques G de Almeida Journal: Int J Mol Sci Date: 2022-04-20 Impact factor: 6.208
Authors: Bruno Braz Bezerra; Gustavo Peixoto Duarte da Silva; Sharton Vinicius Antunes Coelho; Isadora Alonso Correa; Marcos Romario Matos de Souza; Keylla Vitória Gomes Macedo; Bruna Machado Matos; Amilcar Tanuri; Flavio Lemos Matassoli; Luciana Jesus da Costa; James E K Hildreth; Luciana Barros de Arruda Journal: Antiviral Res Date: 2022-07-04 Impact factor: 10.103
Authors: Selvin Noé Palacios-Rápalo; Luis Adrián De Jesús-González; Carlos Daniel Cordero-Rivera; Carlos Noe Farfan-Morales; Juan Fidel Osuna-Ramos; Gustavo Martínez-Mier; Judith Quistián-Galván; Armando Muñoz-Pérez; Víctor Bernal-Dolores; Rosa María Del Ángel; José Manuel Reyes-Ruiz Journal: Front Immunol Date: 2021-12-16 Impact factor: 7.561